Cargando…

Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study

Oral leukoplakia (OL) is a potentially malignant oral disorder. The Gold Standard treatment is to remove surgically the OL. Despite optimal surgery, the recurrence rates are estimated to be 30%. The reason for this is unknown. The aim of this study was to investigate the clinical factors that correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundberg, Jonas, Korytowska, Magdalena, Holmberg, Erik, Bratel, John, Wallström, Mats, Kjellström, Ebba, Blomgren, Johan, Kovács, Anikó, Öhman, Jenny, Sand, Lars, Hirsch, Jan-Michaél, Giglio, Daniel, Kjeller, Göran, Hasséus, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897554/
https://www.ncbi.nlm.nih.gov/pubmed/31810078
http://dx.doi.org/10.1371/journal.pone.0225682
_version_ 1783476979292438528
author Sundberg, Jonas
Korytowska, Magdalena
Holmberg, Erik
Bratel, John
Wallström, Mats
Kjellström, Ebba
Blomgren, Johan
Kovács, Anikó
Öhman, Jenny
Sand, Lars
Hirsch, Jan-Michaél
Giglio, Daniel
Kjeller, Göran
Hasséus, Bengt
author_facet Sundberg, Jonas
Korytowska, Magdalena
Holmberg, Erik
Bratel, John
Wallström, Mats
Kjellström, Ebba
Blomgren, Johan
Kovács, Anikó
Öhman, Jenny
Sand, Lars
Hirsch, Jan-Michaél
Giglio, Daniel
Kjeller, Göran
Hasséus, Bengt
author_sort Sundberg, Jonas
collection PubMed
description Oral leukoplakia (OL) is a potentially malignant oral disorder. The Gold Standard treatment is to remove surgically the OL. Despite optimal surgery, the recurrence rates are estimated to be 30%. The reason for this is unknown. The aim of this study was to investigate the clinical factors that correlate with recurrence after surgical removal of OL. In a prospective study data were collected from 226 patients with OL. Forty-six patients were excluded due to incomplete records or concomitant presence of other oral mucosal diseases. Overall, 180 patients proceeded to analysis (94 women and 86 men; mean age, 62 years; age range, 28–92 years). Clinical data, such as gender, diagnosis (homogeneous/non-homogeneous leukoplakia), location, size, tobacco and alcohol use, verified histopathological diagnosis, and clinical photograph, were obtained. In patients who were eligible for surgery, the OL was surgically removed with a margin. To establish recurrence, a healthy mucosa between the surgery and recurrence had to be confirmed in the records or clinical photographs. Statistical analysis was performed with the level of significance set at P<0.05. Of the 180 patients diagnosed with OL, 57% (N = 103) underwent surgical removal in toto. Recurrence was observed in 43 OL. The cumulative incidence of recurrence of OL was 45% after 4 years and 49% after 5 years. Fifty-six percent (N = 23) of the non-homogeneous type recurred. Among snuff-users 73% (N = 8) cases of OL recurred. A non-homogeneous type of OL and the use of snuff were significantly associated with recurrence after surgical excision (P = 0.021 and P = 0.003, respectively). Recurrence was also significantly associated with cancer transformation (P<0.001). No significant differences were found between recurrence and any of the following: dysplasia, site of lesion, size, multiple vs. solitary OL, gender, age, use of alcohol or smoking. In conclusion, clinical factors that predict recurrence of OL are non-homogeneous type and use of snuff.
format Online
Article
Text
id pubmed-6897554
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68975542019-12-13 Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study Sundberg, Jonas Korytowska, Magdalena Holmberg, Erik Bratel, John Wallström, Mats Kjellström, Ebba Blomgren, Johan Kovács, Anikó Öhman, Jenny Sand, Lars Hirsch, Jan-Michaél Giglio, Daniel Kjeller, Göran Hasséus, Bengt PLoS One Research Article Oral leukoplakia (OL) is a potentially malignant oral disorder. The Gold Standard treatment is to remove surgically the OL. Despite optimal surgery, the recurrence rates are estimated to be 30%. The reason for this is unknown. The aim of this study was to investigate the clinical factors that correlate with recurrence after surgical removal of OL. In a prospective study data were collected from 226 patients with OL. Forty-six patients were excluded due to incomplete records or concomitant presence of other oral mucosal diseases. Overall, 180 patients proceeded to analysis (94 women and 86 men; mean age, 62 years; age range, 28–92 years). Clinical data, such as gender, diagnosis (homogeneous/non-homogeneous leukoplakia), location, size, tobacco and alcohol use, verified histopathological diagnosis, and clinical photograph, were obtained. In patients who were eligible for surgery, the OL was surgically removed with a margin. To establish recurrence, a healthy mucosa between the surgery and recurrence had to be confirmed in the records or clinical photographs. Statistical analysis was performed with the level of significance set at P<0.05. Of the 180 patients diagnosed with OL, 57% (N = 103) underwent surgical removal in toto. Recurrence was observed in 43 OL. The cumulative incidence of recurrence of OL was 45% after 4 years and 49% after 5 years. Fifty-six percent (N = 23) of the non-homogeneous type recurred. Among snuff-users 73% (N = 8) cases of OL recurred. A non-homogeneous type of OL and the use of snuff were significantly associated with recurrence after surgical excision (P = 0.021 and P = 0.003, respectively). Recurrence was also significantly associated with cancer transformation (P<0.001). No significant differences were found between recurrence and any of the following: dysplasia, site of lesion, size, multiple vs. solitary OL, gender, age, use of alcohol or smoking. In conclusion, clinical factors that predict recurrence of OL are non-homogeneous type and use of snuff. Public Library of Science 2019-12-06 /pmc/articles/PMC6897554/ /pubmed/31810078 http://dx.doi.org/10.1371/journal.pone.0225682 Text en © 2019 Sundberg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sundberg, Jonas
Korytowska, Magdalena
Holmberg, Erik
Bratel, John
Wallström, Mats
Kjellström, Ebba
Blomgren, Johan
Kovács, Anikó
Öhman, Jenny
Sand, Lars
Hirsch, Jan-Michaél
Giglio, Daniel
Kjeller, Göran
Hasséus, Bengt
Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title_full Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title_fullStr Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title_full_unstemmed Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title_short Recurrence rates after surgical removal of oral leukoplakia—A prospective longitudinal multi-centre study
title_sort recurrence rates after surgical removal of oral leukoplakia—a prospective longitudinal multi-centre study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897554/
https://www.ncbi.nlm.nih.gov/pubmed/31810078
http://dx.doi.org/10.1371/journal.pone.0225682
work_keys_str_mv AT sundbergjonas recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT korytowskamagdalena recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT holmbergerik recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT brateljohn recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT wallstrommats recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT kjellstromebba recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT blomgrenjohan recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT kovacsaniko recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT ohmanjenny recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT sandlars recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT hirschjanmichael recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT gigliodaniel recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT kjellergoran recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy
AT hasseusbengt recurrenceratesaftersurgicalremovaloforalleukoplakiaaprospectivelongitudinalmulticentrestudy